Results 151 to 160 of about 7,278,095 (302)

The Melbourne rapid field test: Usability and clinical promise. [PDF]

Indian J Ophthalmol
Ichhpujani P.
europepmc   +1 more source

Plasma biomarkers for Alzheimer's disease: a field-test in a memory clinic. [PDF]

J Neurol Neurosurg Psychiatry, 2023
Altomare D, Stampacchia S, Ribaldi F, Tomczyk S, Chevalier C, Poulain G, Asadi S, Bancila B, Marizzoni M, Martins M, Lathuiliere A, Scheffler M, Ashton NJ, Zetterberg H, Blennow K, Kern I, Frias M, Garibotto V, Frisoni GB.   +18 more
europepmc   +1 more source

Field to Transmission Line Coupling: a Test Case within HIRF SE [PDF]

, 2012
Arianos, Sergio, Bertuol, S., Bozzetti, M., Francavilla, Matteo Alessandro, Parmantier J.-P., Pisu, L., Ridel, M., Righero, Marco, Vecchi, Giuseppe, Vipiana, Francesca   +9 more
core   +1 more source

Predicting Epileptogenic Tubers in Patients With Tuberous Sclerosis Complex Using a Fusion Model Integrating Lesion Network Mapping and Machine Learning

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Accurate localization of epileptogenic tubers (ETs) in patients with tuberous sclerosis complex (TSC) is essential but challenging, as these tubers lack distinct pathological or genetic markers to differentiate them from other cortical tubers.
Tinghong Liu, Qi Wang, Suhui Kuang, Dezhi Cao, Ping Ding, Shaohui Zhang, Haihua Wei, Zhirong Wei, Jinshan Xu, Xinyu Huang, Bing Liu, Shuli Liang   +11 more
wiley   +1 more source

Promoting energy conservation through attention control and construct activation: A field test at a campus laundry. [PDF]

PLoS One
Buzinski SG, Jolink TA, Smith OC, Ariely AM, Sheeran P.   +4 more
europepmc   +1 more source

A new static visual field test algorithm: the Ambient Interactive ZEST (AIZE). [PDF]

Sci Rep, 2023
Nomoto H, Matsumoto C, Okuyama S, Kimura S, Inoue S, Yamanaka K, Kusaka S.   +6 more
europepmc   +1 more source

In‐Depth Profiling Highlights the Effect of Efgartigimod on Peripheral Innate and Adaptive Immune Cells in Myasthenia Gravis

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Myasthenia gravis (MG) is an autoimmune disorder characterized by antibody‐mediated complement activation. Efgartigimod, a neonatal Fc receptor (FcRn) antagonist, is approved for treating generalized MG (gMG). However, its modulatory effects on upstream innate and adaptive immune cells remain largely unexplored.
Lei Jin, Liu Dong, Ying Wang, Dingxian He, Chong Yan, Jianying Xi, Haoqin Jiang, Yu Shi, Ming Guan, Chongbo Zhao, Jie Song, Sushan Luo   +11 more
wiley   +1 more source

Effects of the modified field test on exercise-induced peripheral fatigue in non-elite badminton players. [PDF]

Front Physiol
Huang H, Song J, Huang H, Zeng Y, Li X, Liu S.   +5 more
europepmc   +1 more source

Zebrafish aversion to infrasound in an open field test. [PDF]

Front Behav Neurosci, 2022
Scatterty KR, Pitman T, Eckersley T, Schmaltz R, Hamilton TJ.   +4 more
europepmc   +1 more source

ALS With and Without Upper Motor Neuron Signs: A Comparative Study Supporting the Gold Coast Criteria

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective The Gold Coast criteria permit diagnosis of amyotrophic lateral sclerosis (ALS) even without upper motor neuron (UMN) signs. However, whether ALS patients with UMN signs (ALSwUMN) and those without (ALSwoUMN) share similar characteristics and prognoses remains unclear.
Hee‐Jae Jung, E‐nae Cheong, Jungmin So, Heung‐Won Kang, Yangsean Choi, Eun‐Jae Lee, Hyunjin Kim, Young‐Min Lim   +7 more
wiley   +1 more source